| |
| Issue |
Title |
| |
| No 13 (2025) |
Diagnosis and treatment of gout in real clinical practice: The role and place of febuxostat |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, I. V. Madyanov |
| |
| No 13 (2025) |
Relationship between clinical characteristics of psoriasis and psoriatic arthritis and testosterone deficiency in men |
Abstract
PDF (Rus)
|
|
T. S. Panevin, T. V. Korotaeva, L. S. Kruglova, E. G. Zotkin, S. I. Glukhova, E. Yu. Samarkina |
| |
| No 13 (2025) |
Specific aspects of the long-term course of systemic lupus erythematosus (clinical observation and literature review) |
Abstract
PDF (Rus)
|
|
i V. Rakitskaya, G. G. Taradin, A. E. Bagriy, N. F. Yarovaya, A. V. Skorik, L. V. Kononenko, M. V. Homenko, V. S. Strionova |
| |
| No 12 (2025) |
Nephroprotective potential of urate reducing therapy |
Abstract
PDF (Rus)
|
|
L. N. Dolgova, I. G. Krasivina, N. V. Dolgov |
| |
| No 12 (2025) |
Risk of osteoporotic fractures for Central Federal District residents: Results from the epidemiologic study |
Abstract
PDF (Rus)
|
|
O. A. Nikitinskaya, N. V. Toroptsova, E. L. Nasonov |
| |
| No 12 (2025) |
Changes in bone tissue parameters and pain index in the lumbar spine in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
P. S. Kovalenko, I. S. Dydykina, A. V. Smirnov, S. I. Glukhova, E. L. Nasonov |
| |
| No 12 (2025) |
Preclinical rheumatoid arthritis: A modern view of the pathogenesis and possibilities of prevention |
Abstract
PDF (Rus)
|
|
E. S. Aronova, B. S. Belov, G. I. Gridneva |
| |
| No 12 (2025) |
Managing osteoarthritis in the early stages of the disease |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, E. I. Busalaeva, A. G. Timofeeva |
| |
| No 5 (2025) |
Use of the AMS questionnaire to hypogonadism screening in men with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
T. S. Panevin, E. G. Zotkin, I. S. Dydykina, A. S. Potapova, S. I. Glukhova, M. V. Cherkasova, M. E. Diatroptov |
| |
| No 5 (2025) |
Anthropometric parameters as marker of sarcopenia |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, M. V. Kozyreva, N. V. Demin, N. V. Toroptsova |
| |
| No 3 (2025) |
Scolopendra bite in Crimea (clinical observation) |
Abstract
PDF (Rus)
|
|
S. V. Yurieva, G. V. Didenko, E. Yu. Molokova, D. M. Sultanova, A. S. Kolbasenko, A. V. Lapshina, A. I. Yureva |
| |
| No 3 (2025) |
Opportunities for optimizing therapy in the metabolic phenotype of osteoarthritis |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, E. I. Busalaeva |
| |
| No 22 (2024) |
Pleiotropic effects of osteoarthritis therapy |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, N. V. Yaltseva, E. A. Leontieva |
| |
| No 22 (2024) |
Systemic sclerosis associated with pulmonary arterial hypertension: Focus on the visceral form of the disease |
Abstract
PDF (Rus)
|
|
N. N. Yudkina, T. I. Nevretdinov, A. V. Volkov |
| |
| No 12 (2024) |
The prognostic value of hematological indices in systemic inflammatory diseases of connective tissue |
Abstract
PDF (Rus)
|
|
A. V. Manzyuk, T. E. Morozova, A. A. Gertsog, M. A. Litvinova |
| |
| No 12 (2024) |
Use of tofacitinib in psoriatic arthritis (literature review) |
Abstract
PDF (Rus)
|
|
I. A. Shafieva, S. V. Bulgakova, D. P. Kurmaev, E. V. Treneva |
| |
| No 12 (2024) |
Approaches to diagnosis and treatment of osteoporosis and prevention of recurrent fractures in men in therapeutic practice: Clinical cases |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, L. R. Kadyrova, I. N. Kiseleva |
| |
| No 3 (2024) |
Consistent and informed choice of drug and route of administration is key to increasing adherence to osteoarthritis treatment |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, O. G. Alekseeva, P. S. Kovalenko, M. E. Ivanova |
| |
| No 3 (2024) |
Tofacitinib as a means of optimizing the treatment of rheumatoid arthritis at the outpatient stage (clinical cases) |
Abstract
PDF (Rus)
|
|
I. B. Bashkova, I. V. Madyanov |
| |
| No 3 (2024) |
Aseptic necrosis of the femoral head |
Abstract
PDF (Rus)
|
|
Y. S. Filatova, I. N. Solovyov, A. M. Gruzdev, V. V. Bobyleva |
| |
| No 3 (2024) |
Differential diagnosis and treatment of enthesopathies |
Abstract
PDF (Rus)
|
|
I. V. Devald, E. A. Khodus, M. S. Belsner, O. L. Minakina |
| |
| No 21 (2023) |
Prospects for prescription of urate-lowering therapy in patients with asymptomatic hyperuricemia and gout |
Abstract
PDF (Rus)
|
|
E. V. Panina, M. S. Eliseev |
| |
| No 21 (2023) |
Association of serum chemerin levels with complications and comorbidity in rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
E. V. Papichev, Yu. R. Akhverdyan, Yu. V. Polyakova, L. E. Sivordova, B. V. Zavodovsky |
| |
| No 21 (2023) |
Efficacy of tofacitinib in psoriatic arthritis: literature review and case report |
Abstract
PDF (Rus)
|
|
G. I. Gridneva, E. S. Aronova |
| |
| No 21 (2023) |
Osteoarthritis of the hip joints: possibilities of local therapy |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, I. N. Solovyov, A. M. Gruzdev |
| |
| No 13 (2023) |
Tofacitinib in the treatment of rheumatoid arthritis: real-life practice and randomized clinical trial data |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| No 13 (2023) |
Some aspects of anti-inflammatory therapy of osteoarthritis |
Abstract
PDF (Rus)
|
|
Yu. S. Filatova, I. N. Solovyov |
| |
| No 13 (2023) |
Assessment of the quality of life of patients with gonarthrosis treated with a prosthesis of synovial fluid of domestic production |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, Yu. V. Polyakova, E. V. Papichev, Yu. R. Akhverdyan, B. V. Zavodovskii |
| |
| No 6 (2023) |
The role of polymorphic markers of the WWP2 and GDF5 gene in the progression of gonarthrosis in the population of the Central Chernozem region of Russia |
Abstract
PDF (Rus)
|
|
V. B. Novakov, O. N. Novakova, M. I. Churnosov |
| |
| No 21-2 (2021) |
Role of zoledronic acid in treatment of osteoporosis and prevention of fractures |
Abstract
PDF (Rus)
|
|
A. V. Krivova, V. P. Zakharov, A. N. Sharov |
| |
| No 19 (2021) |
Clinical significance of collchicine in pharmacotherapy of cardiovascular pathology in patients with hyperuricemia in rheumatic diseases |
Abstract
PDF (Rus)
|
|
L. E. Sivordova, J. V. Polyakova, E. V. Papichev, Y. R. Akhverdyan, B. V. Zavodovskii |
| |
| No 19 (2021) |
Intra-articular glucocorticoid injection site: best practice guidelines |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, A. M. Lila |
| |
| No 19 (2021) |
Gender characteristics of gout and differences in response to taking xanthioxidase inhibitors |
Abstract
PDF (Rus)
|
|
V. V. Tsurko, M. A. Gromova |
| |
| No 19 (2021) |
Study of risk factors for the osteoporosis development in rheumatoid arthritis in real clinical practice |
Abstract
PDF (Rus)
|
|
E. V. Papichev, Yu. R. Akhverdyan, Yu. V. Polyakova, L. E. Sivordova, B. V. Zavodovskii |
| |
| No 19 (2021) |
Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases |
Abstract
PDF (Rus)
|
|
B. S. Belov, N. V. Muravyeva, M. M. Baranova |
| |
| No 8 (2020) |
Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases |
Abstract
PDF (Rus)
|
|
V. I. Mazurov, I. B. Belyaeva, R. R. Samigullina, A. L. Chudinov, A. M. Dadalova |
| |
| No 8 (2020) |
Many years of experience in using a combination of glucosamine and chondroitin in clinical practice |
Abstract
PDF (Rus)
|
|
I. S. Dydykina, P. S. Kovalenko, A. A. Kovalenko |
| |
| No 8 (2020) |
Bone mineral density and fracture risk in patients with rheumatic diseases |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, A. O. Efremova, N. V. Demin, N. V. Toroptsova |
| |
| No 8 (2020) |
Safe therapy of osteoarthritis: place of topical nonsteroidal anti-inflammatory drugs |
Abstract
PDF (Rus)
|
|
N. V. Chichasova, G. R. Imametdinova, A. M. Lila |
| |
| No 8 (2020) |
COVID-19 and Rheumatology: so far, so close |
Abstract
PDF (Rus)
|
|
B. S. Belov, N. M. Muravyeva, G. M. Tarasova |
| |
| No 8 (2020) |
Interdisciplinary approach to the management of patients with chronic gout |
Abstract
PDF (Rus)
|
|
V. V. Tsurko, M. A. Gromova, N. V. Malysheva |
| |
| No 4 (2020) |
Modern approaches to the treatment of osteoarthritis |
Abstract
PDF (Rus)
|
|
N. V. Chichasova |
| |
| No 4 (2020) |
Clinical manifestations, diagnosis and treatment of gout in the practice of a primary care physician |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 2 (2020) |
Etoricoxib in the treatment of osteoarthritis |
Abstract
PDF (Rus)
|
|
S. G. Anikin, L. I. Alekseeva |
| |
| No 2 (2020) |
Gout treatment: problems, paradoxes, prospects |
Abstract
PDF (Rus)
|
|
M. S. Eliseev |
| |
| No 2 (2020) |
Effects of the use of hyaluronic acid as compared with standard chondroprotectors therapy in patients with various degrees of gonarthrosis |
Abstract
PDF (Rus)
|
|
V. I. Kuznetsov |
| |
| No 2 (2020) |
The use of chondroitin sulfate (Mucosat) for the treatment of chronic back pain and osteoarthritis |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya, I. D. Romanov |
| |
| No 2 (2020) |
The role of targeted synthetic drugs in the treatment of rheumatic diseases: focus on tofacitinib |
Abstract
PDF (Rus)
|
|
D. E. Karateev, E. L. Luchikhina |
| |
| No 21 (2019) |
Glucocorticoid-induced osteoporosis: pathogenesis and prevention |
Abstract
PDF (Rus)
|
|
I. G. Krasivina, L. N. Dolgova, N. V. Dolgov, A. A. Larina |
| |
| No 21 (2019) |
Effectiveness of drugs with delayed-release structurally modified action depending on the phenotype of osteoarthritis |
Abstract
PDF (Rus)
|
|
M. A. Kabalyk |
| |
| No 21 (2019) |
Use of alendronate in the therapy of osteoporosis |
Abstract
PDF (Rus)
|
|
O. B. Ershova |
| |
| No 18 (2019) |
Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
D. E. Karateev, E. L. Luchikhina |
| |
| No 18 (2019) |
Treatment of paraarticular tissue pathology with perifocal combination injections |
Abstract
PDF (Rus)
|
|
N. A. Khitrov |
| |
| No 18 (2019) |
Local forms of diclofenac in the treatment of acute and chronic pain |
Abstract
PDF (Rus)
|
|
G. R. Imametdinova, E. V. Igolkina, N. V. Chichasova |
| |
| No 18 (2019) |
Evaluation of the clinical and anti-destructive effect of an anti-B cell preparation depending on concomitant therapy with basic anti-inflammatory drugs and glucocorticoids in patients with rheumatoid arthritis |
Abstract
PDF (Rus)
|
|
A. V. Kudryavtseva, G. V. Lukina, A. V. Smirnov, S. I. Glukhova |
| |
| No 18 (2019) |
Metabolic risks of hyperuricemia |
Abstract
PDF (Rus)
|
|
L. N. Dolgova, I. G. Krasivina, N. V. Dolgov, D. G. Lugovkina |
| |
| No 18 (2019) |
Aleksandr Mikhaylovich Lila: «Treatment with genetically engineered biological preparations is a research project». |
Abstract
PDF (Rus)
|
|
L. Golovina |
| |
| No 12 (2019) |
Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, A. M. Novikova |
| |
| No 12 (2019) |
Chronic pain in older people: focus on sarcopenia |
Abstract
PDF (Rus)
|
|
A. V. Naumov, V. I. Moroz, N. O. Khovasova, T. M. Manevich, M. M.-B. Balaeva, D. V. Demenok, O. N. Tkacheva |
| |
| No 9 (2019) |
Clinical observation of a patient with ankylosing spondylarthritis (Bechterew’s disease) |
Abstract
PDF (Rus)
|
|
V. V. Tsurko, I. V. Egorov, N. V. Malysheva |
| |
| No 9 (2019) |
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova) |
Abstract
PDF (Rus)
|
|
D. V. Bukhanova, B. S. Belov, G. M. Tarasova, S. K. Soloviev, L. P. Ananyeva, T. V. Popkova, A. V. Gordeev, Yu. V. Muravyov, S. I. Glukhova |
| |
| No 9 (2019) |
Prospects for anti-BLyS treatment of systemic lupus erythematosus |
Abstract
PDF (Rus)
|
|
S. K. Solovyov, A. A. Mesnyankina, E. A. Aseeva |
| |
| No 9 (2019) |
Use of Artra and Artra MSM Forte in osteoarthritis of the large joints and lowback pain |
Abstract
PDF (Rus)
|
|
E. P. Sharapova, L. I. Alekseeva |
| |
| No 9 (2019) |
Bone mineral density status and the need for anti-osteoporotic therapy in postmenopausal women with systemic scleroderma |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, N. V. Demin, A. V. Smirnov, N. V. Toroptsova |
| |
| No 9 (2019) |
Efficacy of Theraflex Chondrocream Forte in the combination treatment of knee osteoarthritis |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 6 (2019) |
Erythema nodosum in rheumatic diseases |
Abstract
PDF (Rus)
|
|
О. N. Egorova, В. S. Belov |
| |
| No 6 (2019) |
The role of chondroprotectors in the pharmacological treatment of osteoarthritis |
Abstract
PDF (Rus)
|
|
L. K. Peshekhonova, P. A. Krasyukov |
| |
| No 1 (2019) |
Tofacitinib: efficiency and safety in long-term use |
Abstract
PDF (Rus)
|
|
N. V. Chichasova |
| |
| No 1 (2019) |
Gout: objective, indications and adherence to uratelowering therapy |
Abstract
PDF (Rus)
|
|
V. V. Tsurko, T. Ye. Morozova, M. A. Gromova, K. M. Krykhivskaya |
| |
| No 1 (2019) |
Bioregulatory drugs in osteoarthritis management |
Abstract
PDF (Rus)
|
|
O. A. Shavlovskaya |
| |
| No 18 (2018) |
Personalization of the use of non-steroidal anti-inflammatory drugs for musculoskeletal diseases. Resolution on the results of the Meeting of Experts of December 13, 2017 |
Abstract
PDF (Rus)
|
|
A. E. Karateev, A. M. Lila, I. S. Dydykina, P. R. Kamchatnov, S. O. Mazurenko, M. V. Naprienko, D. S. Novikova, O. P. Ostroverkhov, M. V. Pchelintsev |
| |
| No 18 (2018) |
Significance of serum procalcitonin for differentiating infections from rheumatic diseases |
Abstract
PDF (Rus)
|
|
G. M. Tarasova, B. S. Belov, A. G. Dilbaryan, D. V. Bukhanova, S. I. Glukova |
| |
| No 12 (2018) |
Change of antioxidant protection indicators in patients with osteoarthritis in the course of the treatment with a combined chondroprotective drug |
Abstract
PDF (Rus)
|
|
E. Yu. Aleksenko, Yu. F. Gatiyatov |
| |
| No 12 (2018) |
Topical diclofenac for the treatment of the musculoskeletal diseases |
Abstract
PDF (Rus)
|
|
G. R. Imametdinova, E. V. Igolkina |
| |
| No 12 (2018) |
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases |
Abstract
PDF (Rus)
|
|
D. V. Bukhanova, B. S. Belov, G. M. Tarasova, Sh. Erdes, T. V. Dubinina, G. V. Lukina, N. V. Demidova, A. V. Volkov, N. N. Yudkina, M. V. Cherkasova, M. E. Diatroptov |
| |
| No 9 (2018) |
Efficacy and safety of amtolmetin guacil in the therapy of osteoarthritis and associated dyspepsia in routine clinical practice: agatha |
Abstract
PDF (Rus)
|
|
L. N. Denisov, E. S. Tsvetkova, E. N. Otteva, A. N. Dubikov, S. P. Yakupova, O. N. Ivanova, N. I. Korshunov, А. P. Vaisberg, R. A. Abyshev, А. V. Tartynov, E. L. Nasonov |
| |
| No 9 (2018) |
Treatment of osteoporosis in patients who had low-energy fractures: challenges of diagnosis and commitment to pathogenetic treatment |
Abstract
PDF (Rus)
|
|
O. V. Dobrovolskaya, N. V. Demin, A. Yu. Feklistov, N. V. Toroptsova |
| |
| No 9 (2018) |
Comparative efcacy and safety of urate-lowering therapy for the treatment of hyperuricemia |
Abstract
PDF (Rus)
|
|
|
| |
| No 9 (2018) |
Joint damage in hiv positive patients |
Abstract
PDF (Rus)
|
|
D. V. Bukhanova, B. S. Belov |
| |
| No 9 (2018) |
The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 6 (2018) |
What can apply for the role of basic therapy for chronic pain in comorbid patients? |
Abstract
PDF (Rus)
|
|
A. V. Naumov, O. N. Tkacheva |
| |
| No 1 (2018) |
NEW OPPORTUNITIES THERAPY IN PATIENTS WITH KNEE JOINT OSTEOARTHRITIS AND METABOLIC SYNDROME |
Abstract
PDF (Rus)
|
|
L. I. Alexeeva, E. A. Taskinа, N. G. Kashevarova, E. P. Sharapova, S. G. Anikin, E. A. Strebkova, T. A. Korotkova, T. A. Raskina, E. V. Zonova, E. N. Oteva, A. G. Dilbaryan |
| |
| No 1 (2018) |
CAN ACECLOFENAC BE CONSIDERED AS A MODERN SUCCESSOR OF THE «GOLD STANDARD» NSAID DYCLOFENAC? REVIEW OF RUSSIAN DATA |
Abstract
PDF (Rus)
|
|
A. E. Karateev, E. Yu. Pogozheva, E. S. Filatova |
| |
| No 1 (2018) |
EFFECT OF LONG-TERM AFFLUTOP THERAPY ON THE ARTHROSONOGRAPHIC CHANGES IN PATIENTS WITH KNEE OSTEOARTHRITIS |
Abstract
PDF (Rus)
|
|
M. S. Svetlova, I. V. Kheifets |
| |
| No 1 (2018) |
NONSTEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATEMENT OF OSTEOARTHROSIS: COMPARATIVE EFFICACY AND TOLERABILITY OF NIMESULIDE |
Abstract
PDF (Rus)
|
|
V. V. Badokin |
| |
| No 20 (2017) |
COPARATIVE CLINICAL ANAYSIS OF VISCOSLIMETARY AND TRAITIONAL METHODS IN THE TREATMENT OF OSTEOARTHROSIS OF THE KNEE JOINTS |
Abstract
PDF (Rus)
|
|
S. V. Ryabinin, V. G. Samoday |
| |
| No 20 (2017) |
OSTEOARTHRITIS: MANAGEMENT OF PATIENTS AND COMPLIANCE TO TREATMENT |
Abstract
PDF (Rus)
|
|
V. V. Tsurko, E. A. Zamyatina, G. G. Bagirova |
| |
| No 20 (2017) |
PNEUMOCYSTIC PNEUMONIA IN RHEUMATIC DISEASES: CURRENT ISSUES IN PROPHYLAXIS |
Abstract
PDF (Rus)
|
|
B. S. Belov, G. M. Tarasova, D. S. Bukhanova |
| |
| No 20 (2017) |
PNEUMOCYSTIC PNEUMONIA IN RHEUMATIC DISEASES: CURRENT ISSUES IN PROPHYLAXIS |
Abstract
PDF (Rus)
|
|
M. S. Eliseev |
| |
| No 1S (2017) |
EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS |
Abstract
PDF (Rus)
|
|
E. P. Sharapova, N. G. Kashevarova, E. M. Zaytseva, S. G. Anikin, T. A. Korotkova, L. I. L.I. Alexeeva |
| |
| No 1S (2017) |
LEFLUNOMIDE IN EARLY RHEUMATOID ARTHRITIS: INCLUSION IN THE TREATMENT STRATEGY AND PROSPECTS |
Abstract
PDF (Rus)
|
|
D. E. Karateev, E. V. Orlova |
| |
| No 1S (2017) |
TOPICAL ISSUES OF OSTEOARTHRITIS TREATMENT IN CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
L. K. Poshekhonova, D. V. Poshekhonov, P. A. Krasyukov |
| |
| No 1S (2017) |
ASSESSMENT OF 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES WITH THE RUSSIAN MODEL OF FRAX® IN A POPULATION-BASED SAMPLE 5 REGIONS OF RUSSIA |
Abstract
PDF (Rus)
|
|
O. A. Nikitinskaya, N. V. Toroptsova |
| |
| No 1S (2017) |
RADIOLOGICAL PROGRESSION OF KNEE OSTEOARTHRITIS ON THE BACKGROUND OF PROLONGED TREATMENT WITH ALFLUTOP (5 YEAR FOLLOW-UP) |
Abstract
PDF (Rus)
|
|
M. S. Svetlova |
| |
| No 17 (2017) |
USE OF NIMESULIDE IN TREATMENT OF GOUT |
Abstract
PDF (Rus)
|
|
M. S. Eliseev, О. V. Zhelyabina |
| |
| No 17 (2017) |
GOUTY ARTHRITIS – MODERN VIEW OF THE PROBLEM |
Abstract
PDF (Rus)
|
|
V. I. Mazurov, M. S. Petrova, O. V. Inamova, M. M. Museichuk |
| |
| No 17 (2017) |
FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS |
Abstract
PDF (Rus)
|
|
M. S. Petrova, V. I. Mazurov, O. V. Inamova |
| |
| No 17 (2017) |
POSSIBILITIES TO USE NON-STEROID ANTI-INLAMMATORY DRUGS IN CLINICAL PRACTICE: FOCUS ON NIMESULIDE |
Abstract
PDF (Rus)
|
|
Y. A. Olyunin, N. Y. Nikishina |
| |
| No 17 (2017) |
REASONABLE THERAPY OF PAIN SYNDROMES OF DISEASES OF T H E MUSCULOSKELETAL SYSTEM |
Abstract
PDF (Rus)
|
|
L. N. Denisov |
| |
| No 17 (2017) |
MODERN OSTEOARTHRITIS THERAPY: ALFLUTOP IN CLINICAL PRACTICE, EXPERIMENTAL AND CLINICAL DATA |
Abstract
PDF (Rus)
|
|
N. V. Chichasova |
| |
| 1 - 100 of 136 Items |
1 2 > >>
|
